Cryoport (CYRX) Misses Q4 EPS by 6c, provides guidance

Cryoport (NASDAQ: CYRX) reported Q4 EPS of ($0.27), $0.06 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $45.45 million versus the consensus estimate of $42.93 million.

GUIDANCE:

Cryoport sees FY2026 revenue of $190-194 million, versus the consensus of $189.5 million.

For earnings history and earnings-related data on Cryoport (CYRX) click here.

You May Also Be Interested In

• U.S. Issues amended Iran-related general license
• Perplexity to use Nvidia's new CPUs for AI agent tasks
• ISS recommends Genesco shareholders back all nine board nominees